147 related articles for article (PubMed ID: 30017327)
1. Impact of a program ensuring consistent response to acute drops in lung function in children with cystic fibrosis.
Schechter MS; Schmidt HJ; Williams R; Norton R; Taylor D; Molzhon A
J Cyst Fibros; 2018 Nov; 17(6):769-778. PubMed ID: 30017327
[TBL] [Abstract][Full Text] [Related]
2. Characteristics and outcomes of oral antibiotic treated pulmonary exacerbations in children with cystic fibrosis.
Hoppe JE; Wagner BD; Accurso FJ; Zemanick ET; Sagel SD
J Cyst Fibros; 2018 Nov; 17(6):760-768. PubMed ID: 29921503
[TBL] [Abstract][Full Text] [Related]
3. Rationale and design of a randomized trial of home electronic symptom and lung function monitoring to detect cystic fibrosis pulmonary exacerbations: the early intervention in cystic fibrosis exacerbation (eICE) trial.
Lechtzin N; West N; Allgood S; Wilhelm E; Khan U; Mayer-Hamblett N; Aitken ML; Ramsey BW; Boyle MP; Mogayzel PJ; Goss CH
Contemp Clin Trials; 2013 Nov; 36(2):460-9. PubMed ID: 24055998
[TBL] [Abstract][Full Text] [Related]
4. Improved outcomes in cystic fibrosis using modified
Reamer C; O'Malley C; Nufer J; Savant A
BMJ Open Qual; 2020 Jul; 9(3):. PubMed ID: 32675178
[TBL] [Abstract][Full Text] [Related]
5. Standardized Treatment of Pulmonary Exacerbations (STOP) study: Physician treatment practices and outcomes for individuals with cystic fibrosis with pulmonary Exacerbations.
West NE; Beckett VV; Jain R; Sanders DB; Nick JA; Heltshe SL; Dasenbrook EC; VanDevanter DR; Solomon GM; Goss CH; Flume PA;
J Cyst Fibros; 2017 Sep; 16(5):600-606. PubMed ID: 28457954
[TBL] [Abstract][Full Text] [Related]
6. Lung function changes before and after pulmonary exacerbation antimicrobial treatment in cystic fibrosis.
Wagener JS; VanDevanter DR; Konstan MW; Pasta DJ; Millar SJ; Morgan WJ
Pediatr Pulmonol; 2020 Mar; 55(3):828-834. PubMed ID: 31746561
[TBL] [Abstract][Full Text] [Related]
7. Early life growth patterns persist for 12 years and impact pulmonary outcomes in cystic fibrosis.
Sanders DB; Zhang Z; Farrell PM; Lai HJ;
J Cyst Fibros; 2018 Jul; 17(4):528-535. PubMed ID: 29396025
[TBL] [Abstract][Full Text] [Related]
8. Correspondence between lung function and symptom measures from the Cystic Fibrosis Respiratory Symptom Diary-Chronic Respiratory Infection Symptom Score (CFRSD-CRISS).
Gold LS; Patrick DL; Hansen RN; Goss CH; Kessler L
J Cyst Fibros; 2019 Nov; 18(6):886-893. PubMed ID: 31126901
[TBL] [Abstract][Full Text] [Related]
9. Correspondence between symptoms and preference-based health status measures in the STOP study.
Gold LS; Patrick DL; Hansen RN; Beckett V; Goss CH; Kessler L
J Cyst Fibros; 2019 Mar; 18(2):251-264. PubMed ID: 30170756
[TBL] [Abstract][Full Text] [Related]
10. Improving inpatient cystic fibrosis pulmonary exacerbation care: two success stories.
Antos NJ; Quintero DR; Walsh-Kelly CM; Noe JE; Schechter MS
BMJ Qual Saf; 2014 Apr; 23 Suppl 1():i33-i41. PubMed ID: 24608549
[TBL] [Abstract][Full Text] [Related]
11. Treatment Setting and Outcomes of Cystic Fibrosis Pulmonary Exacerbations.
Schechter MS; VanDevanter DR; Pasta DJ; Short SA; Morgan WJ; Konstan MW;
Ann Am Thorac Soc; 2018 Feb; 15(2):225-233. PubMed ID: 29140726
[TBL] [Abstract][Full Text] [Related]
12. Cystic fibrosis clinical score: a new scoring system to evaluate acute pulmonary exacerbation.
Kanga J; Kuhn R; Craigmyle L; Haverstock D; Church D
Clin Ther; 1999 Aug; 21(8):1343-56. PubMed ID: 10485506
[TBL] [Abstract][Full Text] [Related]
13. Improved recognition of lung function decline as signal of cystic fibrosis pulmonary exacerbation: a Cystic Fibrosis Learning Network Innovation Laboratory quality improvement initiative.
List R; Solomon G; Bichl S; Horton BJ; Shen S; Corcoran B; Sadeghi H; Britto MT; Ren C; Albon D;
BMJ Open Qual; 2023 Dec; 12(4):. PubMed ID: 38154821
[TBL] [Abstract][Full Text] [Related]
14. The association of area deprivation and state child health with respiratory outcomes of pediatric patients with cystic fibrosis in the United States.
Oates G; Rutland S; Juarez L; Friedman A; Schechter MS
Pediatr Pulmonol; 2021 May; 56(5):883-890. PubMed ID: 33258546
[TBL] [Abstract][Full Text] [Related]
15. Pulmonary exacerbations and acute declines in lung function in patients with cystic fibrosis.
Wagener JS; Williams MJ; Millar SJ; Morgan WJ; Pasta DJ; Konstan MW
J Cyst Fibros; 2018 Jul; 17(4):496-502. PubMed ID: 29685810
[TBL] [Abstract][Full Text] [Related]
16. Progression of Lung Disease in Preschool Patients with Cystic Fibrosis.
Stanojevic S; Davis SD; Retsch-Bogart G; Webster H; Davis M; Johnson RC; Jensen R; Pizarro ME; Kane M; Clem CC; Schornick L; Subbarao P; Ratjen FA
Am J Respir Crit Care Med; 2017 May; 195(9):1216-1225. PubMed ID: 27943680
[TBL] [Abstract][Full Text] [Related]
17. Approach to treating cystic fibrosis pulmonary exacerbations varies widely across US CF care centers.
Kraynack NC; Gothard MD; Falletta LM; McBride JT
Pediatr Pulmonol; 2011 Sep; 46(9):870-81. PubMed ID: 21465675
[TBL] [Abstract][Full Text] [Related]
18. Impact of pulmonary exacerbations and lung function on generic health-related quality of life in patients with cystic fibrosis.
Solem CT; Vera-Llonch M; Liu S; Botteman M; Castiglione B
Health Qual Life Outcomes; 2016 Apr; 14():63. PubMed ID: 27097977
[TBL] [Abstract][Full Text] [Related]
19. Pulmonary function outcomes for assessing cystic fibrosis care.
Wagener JS; Elkin EP; Pasta DJ; Schechter MS; Konstan MW; Morgan WJ;
J Cyst Fibros; 2015 May; 14(3):376-83. PubMed ID: 25498960
[TBL] [Abstract][Full Text] [Related]
20. Risk stratification model to detect early pulmonary disease in infants with cystic fibrosis diagnosed by newborn screening.
Britton LJ; Oates GR; Oster RA; Self ST; Troxler RB; Hoover WC; Gutierrez HH; Harris WT
Pediatr Pulmonol; 2016 Nov; 51(11):1168-1176. PubMed ID: 27556254
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
